{"id":48283,"date":"2022-09-13T02:01:52","date_gmt":"2022-09-13T00:01:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/"},"modified":"2022-09-13T02:01:52","modified_gmt":"2022-09-13T00:01:52","slug":"canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/","title":{"rendered":"CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September"},"content":{"rendered":"<div>\n<p>BEIJING &amp; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;<b>CANbridge Pharmaceuticals, Inc.<\/b> (HKEX:1228) , a China and U.S.-based global biopharmaceutical company committed to the research, development and commercialization of transformative therapies to treat rare diseases and oncology, today announced that it will be participating in two upcoming investor conferences.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220912005900\/en\/1043477\/5\/01_CANbridge_Logo_1.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220912005900\/en\/1043477\/21\/01_CANbridge_Logo_1.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Morgan Stanley 20th Annual Global Healthcare Conference (New York)<\/b><\/p>\n<ul class=\"bwlistcircle\">\n<li>\nCEO, James Xue, PhD, to participate in a fireside chat on Wednesday, September 14, 2022 at 4:05 PM EST\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<b>J.P. Morgan Global Healthcare Shanghai Conference (Shanghai)<\/b><\/p>\n<ul class=\"bwlistcircle\">\n<li>\nSeptember 26- 27\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\n<b>About CANbridge Pharmaceuticals Inc.<\/b>\n<\/p>\n<p>\nCANbridge Pharmaceuticals Inc. (HKEX:1228) is a China and U.S.-based global biopharmaceutical company committed to the research, development and commercialization of transformative therapies for rare disease and rare oncology. CANbridge has a differentiated drug portfolio, with three approved drugs and a pipeline of 10 assets, targeting prevalent rare disease and rare oncology indications that have unmet needs and significant market potential. These include Hunter syndrome and other lysosomal storage disorders, complement-mediated disorders, hemophilia A, metabolic disorders, rare cholestatic liver diseases and neuromuscular diseases, as well as glioblastoma multiforme. CANbridge is also building next-generation gene therapy development capability through a combination of collaboration with world-leading researchers and biotech companies and internal capacity. CANbridge global partners include: Apogenix, GC Pharma, Mirum, Wuxi Biologics, Privus, the UMass Chan Medical School, the University of Washington School of Medicine, Scriptr Global and LogicBio.\n<\/p>\n<p>\nFor more on CANbridge Pharmaceuticals Inc., please go to: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.canbridgepharma.com&amp;esheet=52884637&amp;newsitemid=20220912005900&amp;lan=en-US&amp;anchor=www.canbridgepharma.com&amp;index=1&amp;md5=8506983ff918b835e4c39ed5cc81d1a1\" rel=\"nofollow noopener\" shape=\"rect\">www.canbridgepharma.com<\/a>.\n<\/p>\n<p>\n<b>Forward-Looking Statements<\/b>\n<\/p>\n<p>\nThe forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the data on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>U.S. Investor Relations:<\/b><br \/>Chris Brinzey<br \/>\n<br \/>ICR Westwicke<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;l&#x74;&#x6f;&#x3a;&#67;h&#x72;&#x69;&#x73;&#46;b&#x72;&#x69;&#x6e;&#122;e&#x79;&#x40;&#x77;&#101;s&#x74;&#x77;&#x69;&#99;k&#x65;&#x2e;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x43;&#104;&#x72;&#x69;s&#x2e;&#98;r&#x69;&#110;z&#x65;&#121;&#x40;&#x77;e&#x73;&#116;w&#x69;&#99;k&#x65;&#46;&#x63;&#x6f;&#109;<\/a>\n<\/p>\n<p>\n<b>China Investor Relations<\/b><br \/>CANbridge Pharmaceuticals Inc.<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x69;&#114;&#x40;&#99;&#x61;&#110;&#x62;&#114;&#x69;&#100;&#x67;&#101;&#x70;&#104;&#x61;&#114;&#x6d;&#97;&#x2e;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#x72;&#x40;&#x63;&#x61;&#110;&#98;&#114;&#105;dge&#x70;&#x68;&#x61;&#x72;&#x6d;&#x61;&#46;&#99;&#111;m<\/a>\n<\/p>\n<p>\n<b>Media:<\/b><br \/>Deanne Eagle<br \/>\n<br \/>Planet Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;t&#111;&#x3a;&#100;&#x65;a&#110;&#x6e;&#101;&#x40;p&#x6c;&#x61;&#110;&#x65;t&#x63;o&#109;&#x6d;&#117;&#x6e;i&#99;&#x61;&#116;&#x69;o&#110;&#x73;&#46;&#x6e;y&#x63;\" rel=\"nofollow noopener\" shape=\"rect\">d&#101;&#97;&#x6e;&#x6e;e&#64;&#112;&#108;&#x61;&#x6e;et&#99;&#111;&#x6d;&#x6d;un&#105;&#x63;&#x61;&#x74;i&#111;&#110;&#x73;&#x2e;&#x6e;y&#99;<\/a><br \/>917.837.5866\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BEIJING &amp; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;CANbridge Pharmaceuticals, Inc. (HKEX:1228) , a China and U.S.-based global biopharmaceutical company committed to the research, development and commercialization of transformative therapies to treat rare diseases and oncology, today announced that it will be participating in two upcoming investor conferences. Morgan Stanley 20th Annual Global Healthcare Conference (New York) CEO, James &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48283","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BEIJING &amp; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;CANbridge Pharmaceuticals, Inc. (HKEX:1228) , a China and U.S.-based global biopharmaceutical company committed to the research, development and commercialization of transformative therapies to treat rare diseases and oncology, today announced that it will be participating in two upcoming investor conferences. Morgan Stanley 20th Annual Global Healthcare Conference (New York) CEO, James ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-13T00:01:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220912005900\/en\/1043477\/21\/01_CANbridge_Logo_1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September\",\"datePublished\":\"2022-09-13T00:01:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\\\/\"},\"wordCount\":416,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220912005900\\\/en\\\/1043477\\\/21\\\/01_CANbridge_Logo_1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\\\/\",\"name\":\"CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220912005900\\\/en\\\/1043477\\\/21\\\/01_CANbridge_Logo_1.jpg\",\"datePublished\":\"2022-09-13T00:01:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220912005900\\\/en\\\/1043477\\\/21\\\/01_CANbridge_Logo_1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220912005900\\\/en\\\/1043477\\\/21\\\/01_CANbridge_Logo_1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September - Pharma Trend","og_description":"BEIJING &amp; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;CANbridge Pharmaceuticals, Inc. (HKEX:1228) , a China and U.S.-based global biopharmaceutical company committed to the research, development and commercialization of transformative therapies to treat rare diseases and oncology, today announced that it will be participating in two upcoming investor conferences. Morgan Stanley 20th Annual Global Healthcare Conference (New York) CEO, James ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-13T00:01:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220912005900\/en\/1043477\/21\/01_CANbridge_Logo_1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September","datePublished":"2022-09-13T00:01:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/"},"wordCount":416,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220912005900\/en\/1043477\/21\/01_CANbridge_Logo_1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/","url":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/","name":"CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220912005900\/en\/1043477\/21\/01_CANbridge_Logo_1.jpg","datePublished":"2022-09-13T00:01:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220912005900\/en\/1043477\/21\/01_CANbridge_Logo_1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220912005900\/en\/1043477\/21\/01_CANbridge_Logo_1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/canbridge-pharmaceuticals-to-participate-in-two-investor-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48283"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48283\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}